Marty McCary

Dr. Marty McCary, FDA Commissioner and a seasoned contributor, delves into groundbreaking discussions on autism research and FDA policy. He shares insights on a new link between acetaminophen during pregnancy and autism risk, shedding light on important study findings. Dr. McCary also highlights innovative treatments involving leucovorin for autistic children and emphasizes his aims for the FDA, including speeding up drug approvals and improving children's nutrition. Additionally, he addresses reforming sunscreen regulations to enhance safety.

Marty McCary, the FDA Commissioner, discusses the agency's groundbreaking decision to remove the black box warning on estrogen therapy for menopause. Joanne Pinkerton, a menopause specialist, highlights the clinical benefits of hormone replacement therapy, especially when started early. They delve into how the 2002 Women's Health Initiative study led to a decline in therapy, and McCary reassesses the risks associated with hormone therapy. The conversation also addresses concerns about access and potential overuse after the warning's removal.

Marty McCary is a renowned surgeon and public policy researcher, while Cara Anthony investigates trauma and violence as a reporter, and Rachel Yehuda is a distinguished professor studying intergenerational trauma. They discuss how outdated medical guidelines on peanut allergies led to unintended consequences and highlight the shocking legacy of trauma within communities, particularly among descendants of Holocaust survivors. The conversation dives into the importance of understanding these ripple effects for better health outcomes and emotional healing.

In a groundbreaking discussion, Dr. Marty McCary, an FDA commissioner, and Dr. Rachel Rubin, a menopause and HRT expert, delve into the pivotal removal of boxed warnings on hormone replacement therapy (HRT). They unveil the positive implications for women's health, debunk myths that have caused unnecessary fear, and stress the long-term benefits of HRT, including reducing heart disease and osteoporosis risks. The conversation highlights the need for better clinician education and informed consent, empowering women to make knowledgeable health choices.

In this insightful discussion, former President Donald Trump emphasizes the need for reduced acetaminophen use during pregnancy and advocates for revised vaccine schedules in autism policy. Robert F. Kennedy Jr. critiques prior NIH studies on autism, proposing a fresh exposomics-driven approach to uncovering its causes. Dr. Marty McCary outlines FDA initiatives, including updates to acetaminophen labeling and new therapies for children with autism, sparking a vital conversation on the environmental triggers vs. diagnostic changes in the autism epidemic.